⌘+K

Latest share price

SEK

14.9

-1.66%

20 Nov 2026 17:29 CET

Fair value range

SEK

16.0

—

30.0

23 Oct 2026

Market cap

SEK

520

m

Bactiguard

Healthcare

2026-10-23

Licence engine gaining momentum - Q3 review

Net sales grew 21% Y/Y to SEK55m, with licence revenue of SEK41m, while adj. EBITDA reached SEK20m, corresponding to a margin of 34%. 9M adj. EBITDA of SEK31m already...

Post-Results Note

Kristofer Liljeberg

Maria Karlsson Osipova

Licence engine gaining momentum - Q3 review

Strong BD and stronger EBITDA - Q3 initial

Further progress towards stability expected - Q3 preview

Bactiguard

Healthcare

2026-10-22

Strong BD and stronger EBITDA - Q3 initial

Net sales of SEK55m were 6% above our estimate (+21% Y/Y, +24% at CER), while adj. EBITDA of SEK20m was more than double our SEK9m, giving a 34% margin vs our 17%...

News

Kristofer Liljeberg

Maria Karlsson Osipova

Licence engine gaining momentum - Q3 review

Strong BD and stronger EBITDA - Q3 initial

Further progress towards stability expected - Q3 preview

Bactiguard

Healthcare

2026-10-01

Further progress towards stability expected - Q3 preview

We expect further progress towards stability in Q3, forecasting net sales of SEK52m, corresponding to c14% Y/Y growth (including a <1%-point FX effect), and EBITDA of...

Pre-Results Note

Kristofer Liljeberg

Maria Karlsson Osipova

Licence engine gaining momentum - Q3 review

Strong BD and stronger EBITDA - Q3 initial

Further progress towards stability expected - Q3 preview

Price chart

Price

Fair range high value

Fair range low value

Year

2024

2025

2026e

2027e

2028e

EPS

-0.85

-0.22

-0.30

-0.26

-0.03

EPS (Adj.)

-0.85

-0.22

-0.07

-0.14

-0.03

Sales Growth

19.89%

-10.60%

-3.36%

14.22%

14.97%

EPS Growth (Adj.)

-35.00%

421.19%

90.36%

P/E

P/E (Adj.)

EV/EBITA

-21.1

-186.9

-50.0

-93.6

141.3

EV/EBITDA

34.2

14.1

17.9

12.4

7.9

Learn more

Key facts

Sector

Healthcare

Country

Sweden

Tickers

BACTIB@SS, BACTIb.ST

CEO

Christine Lind

CFO

Patrick Bach

About DNB Carnegie Access

DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.

Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.

Private Banking

Tailored wealth management. Your financial future, personalized.

Montrose

A digital investment platform designed for passionate investors.

DNB Carnegie

Leading Nordic investment bank and wealth management.

© Copyright DNB Carnegie Investment Bank AB